ES2150440T3 - Producto nutritivo para pacientes que padecen una enfermedad pulmonar. - Google Patents

Producto nutritivo para pacientes que padecen una enfermedad pulmonar.

Info

Publication number
ES2150440T3
ES2150440T3 ES93904981T ES93904981T ES2150440T3 ES 2150440 T3 ES2150440 T3 ES 2150440T3 ES 93904981 T ES93904981 T ES 93904981T ES 93904981 T ES93904981 T ES 93904981T ES 2150440 T3 ES2150440 T3 ES 2150440T3
Authority
ES
Spain
Prior art keywords
acid
margin
relation
nutritive product
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93904981T
Other languages
English (en)
Inventor
Stephen Joseph Demichele
Timothy James Gregory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2150440T3 publication Critical patent/ES2150440T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/80Geriatric
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/801Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN PRODUCTO NUTRITIVO LIQUIDO PARA COMIDA ENTERAL CONTIENE UNA FUENTE GRASA QUE PROPORCIONA LOS EFECTOS DESEABLES CUANDO SE ALIMENTA A PACIENTES PULMONARES. LA FUENTE GRASA PROPORCIONA UNA RELACION POR PESO DE ACIDOS GRASOS N - 6 A N - 3 EN EL MARGEN ENTRE 1.5 A 3.0, UNA RELACION DE ACIDO LINOLEICO (18 : 2N6) A ACIDO ALFA - LINOLENICO (18 : 3N3) EN EL MARGEN ENTRE 3.0 Y 10.0, Y UNA RELACION DE LA SUMA DE ACIDO EICOSAPENTANOICO (20 : 5N3) Y ACIDO DOCOSAHEXAENOICO (22 : 6N3) A ACIDO GAMMA - LINOLENICO (18 : 3N6) EN EL MARGEN ENTRE 1.0 Y 10.0. EN UNA VERSION ANTERIORMENTE REFERIDA EL PRODUCTO NUTRITIVO CONTIENE CANTIDADES DE NUTRIENTE QUE TIENE PROPIEDADES ANTIOXIDANTES "IN VIVO", TALES COMO CAROTENO - BETA, VITAMINA E, VITAMINA C, SELENIO, Y TAURINA.
ES93904981T 1992-03-31 1993-02-09 Producto nutritivo para pacientes que padecen una enfermedad pulmonar. Expired - Lifetime ES2150440T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/860,857 US5223285A (en) 1992-03-31 1992-03-31 Nutritional product for pulmonary patients

Publications (1)

Publication Number Publication Date
ES2150440T3 true ES2150440T3 (es) 2000-12-01

Family

ID=25334192

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93904981T Expired - Lifetime ES2150440T3 (es) 1992-03-31 1993-02-09 Producto nutritivo para pacientes que padecen una enfermedad pulmonar.

Country Status (11)

Country Link
US (1) US5223285A (es)
EP (1) EP0656754B1 (es)
JP (1) JPH0811048B2 (es)
AU (1) AU659931B2 (es)
CA (1) CA2129452C (es)
DE (1) DE69329201T2 (es)
ES (1) ES2150440T3 (es)
GR (1) GR3034742T3 (es)
MX (1) MX9301787A (es)
NZ (1) NZ249397A (es)
WO (1) WO1993019624A1 (es)

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9200541D0 (sv) * 1992-02-24 1992-02-24 Kabi Pharmacia Ab New usee of omega-3-fatty acids
US5234702A (en) * 1992-03-19 1993-08-10 Abbott Laboratories Antioxidant system for powdered nutritional products
WO1994027628A1 (en) * 1993-05-28 1994-12-08 Abbott Laboratories Enteral nutritional product
US5514656A (en) * 1993-05-28 1996-05-07 Abbott Laboratories Method of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapy
WO1994027450A1 (en) * 1993-05-28 1994-12-08 Abbott Laboratories Method of adding fish oil to an enteral nutritional product
US5480872A (en) * 1993-05-28 1996-01-02 Abbott Laboratories Method of providing enternal nutritional support to persons infected with human immunodeficiency virus
US5547927A (en) * 1993-05-28 1996-08-20 Abbott Laboratories Enteral nutritional product for patients undergoing radiation therapy and/or chemotherapy
US5700782A (en) * 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product
US5403826A (en) * 1993-05-28 1995-04-04 Abbott Laboratories Nutritional product for persons infected with human immunodeficiency virus
ATE186174T1 (de) * 1993-08-20 1999-11-15 Nestle Sa Lipidzusammensetzung für nahrungsmittel
US5723446A (en) * 1993-12-23 1998-03-03 Nestec Ltd. Enteral formulation designed for optimized nutrient absorption and wound healing
US6136858A (en) 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US5492899A (en) * 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
US5700590A (en) * 1994-01-10 1997-12-23 Abbott Laboratories Nutritional formula with ribo-nucleotides
US5855949A (en) * 1994-01-10 1999-01-05 Mclean; Linsey Dietary system high in oil intake
US5484623A (en) * 1994-01-10 1996-01-16 Mclean; Linsey Dietary system high in oil intake for the treatment of obesity and for the lowering of saturated fats
US5550106A (en) * 1994-03-04 1996-08-27 Bristol-Myers Squibb Company Low buffer nutritional composition
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
DE4417851C1 (de) * 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung
CA2150741A1 (en) * 1994-06-17 1995-12-18 Susan Trimbo Pediatric lipid emulsion
WO1995035038A1 (de) * 1994-06-20 1995-12-28 Peter Singer Diätetisches lebensmittel und dessen verwendung
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
US5578334A (en) * 1995-04-07 1996-11-26 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum with fat blends
CA2173545C (en) * 1995-04-07 2004-06-29 Kalyana Sundram Increasing the hdl level and the hdl/ldl ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
US6630192B2 (en) 1995-04-07 2003-10-07 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
US5639471A (en) * 1995-06-06 1997-06-17 Campbell Soup Company Method for determining diet program effectiveness
WO1996039053A2 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Mineral supplements for dietetic food
US6039989A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Prepackaged therapeutic meal for treatment of diet-responsive conditions
EP0833571A2 (en) * 1995-06-06 1998-04-08 Campbell Soup Company Compliance support package for increasing health management system compliance
CA2223102A1 (en) * 1995-06-06 1996-12-12 Campbell Soup Company Therapeutic system for dietary health management
US5709855A (en) * 1995-09-22 1998-01-20 Bockow; Barry I. Compositions of spirulina algae and omega fatty acids for treatment of inflammation and pain
JPH09194364A (ja) * 1996-01-22 1997-07-29 Snow Brand Milk Prod Co Ltd ビタミンa吸収促進剤
US6200624B1 (en) * 1996-01-26 2001-03-13 Abbott Laboratories Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6340485B1 (en) * 1996-06-03 2002-01-22 Croda International Plc Compositions and uses thereof
WO1997046220A1 (en) * 1996-06-03 1997-12-11 Croda International Plc Vegetable oil compositions
US5705735A (en) * 1996-08-09 1998-01-06 Medical Graphics Corporation Breath by breath nutritional requirements analyzing system
US5869118A (en) * 1996-11-13 1999-02-09 Abbott Laboratories Gellan gum to improve physical stability of liquid nutritional products
DE69622722T2 (de) 1996-11-20 2003-02-27 N.V. Nutricia, Zoetermeer Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselsyndroms
US6245340B1 (en) * 1996-12-03 2001-06-12 Parvin Youssefyeh Method of improving the immune response and compositions therefor
US6166076A (en) * 1996-12-13 2000-12-26 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Taste enhancing food additives
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US6200950B1 (en) 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US7138431B1 (en) * 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6130244A (en) 1998-02-25 2000-10-10 Abbott Laboratories Product and method to reduce stress induced immune suppression
US6194379B1 (en) 1998-05-01 2001-02-27 Abbott Laboratories Elemental enteral formula
US7141266B2 (en) * 1998-05-21 2006-11-28 Beech-Nut Nutrition Corporation Baby-food compositions enhancing visual acuity and methods therefor
US7413759B2 (en) * 1998-05-21 2008-08-19 Beech-Nut Nutrition Corporation Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
US6579551B1 (en) 1998-05-21 2003-06-17 Beech-Nut Nutrition Corporation Baby-food compositions containing egg yolk and methods therefor
US6149964A (en) * 1998-05-21 2000-11-21 Beech-Nut Nutrition Corporation Egg yolk-containing baby food compositions and methods therefor
WO2000030664A1 (en) * 1998-11-25 2000-06-02 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases
US6156354A (en) * 1999-01-29 2000-12-05 Brandeis University Hyper-absorption of vitamin E dispersed in milks
AU730929B2 (en) * 1999-07-06 2001-03-22 Nestec S.A. Composition and method for prolonging the useful life of enteral feeding tubes
EP1090636A1 (en) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
RU2167568C1 (ru) * 1999-09-20 2001-05-27 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ приготовления банановой основы для замутненных напитков
RU2165182C1 (ru) * 1999-09-20 2001-04-20 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ приготовления банановой основы для замутненных напитков
RU2171069C2 (ru) * 1999-09-20 2001-07-27 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ приготовления банановой основы для замутненных напитков
RU2170526C2 (ru) * 1999-09-20 2001-07-20 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ приготовления банановой основы для замутненных напитков
RU2165183C1 (ru) * 1999-09-20 2001-04-20 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ приготовления банановой основы для замутненных напитков
RU2170525C2 (ru) * 1999-09-20 2001-07-20 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ приготовления банановой основы для замутненных напитков
RU2167563C1 (ru) * 1999-09-20 2001-05-27 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ получения банановой основы для замутненных напитков
RU2165178C1 (ru) * 1999-09-20 2001-04-20 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ приготовления основы из плодов банана для замутненных напитков
RU2167565C1 (ru) * 1999-09-20 2001-05-27 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ приготовления основы из плодов банана для замутненных напитков
RU2167569C1 (ru) * 1999-09-20 2001-05-27 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ приготовления банановой основы для замутненных напитков
RU2170528C2 (ru) * 1999-09-20 2001-07-20 Краснодарский научно-исследовательский институт хранения и переработки сельскохозяйственной продукции Способ приготовления банановой основы для замутненных напитков
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
CA2704975A1 (en) * 1999-10-13 2001-05-31 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
NO313076B1 (no) * 1999-12-28 2002-08-12 Pronova Biocare As Flytende n¶rings- og/eller nytelsesmiddel og fremgangsmåte for fremstilling derav
HU227182B1 (en) 2000-03-06 2010-09-28 Andras Javor Lecitin-ascorbic acid combination
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
US6596302B2 (en) 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US7208180B2 (en) 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
US6667064B2 (en) 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
NZ524869A (en) * 2000-09-22 2005-06-24 Mars Uk Ltd Food supplement
CA2427289C (en) * 2000-11-16 2006-10-31 Morinaga Milk Industry Co., Ltd. Fat composition and hexacosanoic acid depressant for oral or enteral administration
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
EP1372641A4 (en) * 2001-03-05 2004-08-25 Stephen P Ernest ENTERAL FORMULATION
US7169770B2 (en) 2001-04-24 2007-01-30 Lonza Ltd. Method of enhancing reproductive performance in sows
US6605310B2 (en) 2001-06-06 2003-08-12 Nestec S.A. Calorically dense liquid oral supplement
AU784852B2 (en) * 2001-08-10 2006-07-06 Mars, Incorporated Canine support diet
US7449451B2 (en) * 2001-08-29 2008-11-11 Premier Micronutrient Corporation Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks
US6849613B2 (en) 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
FR2839887A1 (fr) * 2002-05-22 2003-11-28 Synergia Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
US9138408B2 (en) * 2002-06-21 2015-09-22 L'oreal Use of taurine for treating alopecia
WO2004093824A2 (en) * 2003-04-08 2004-11-04 Fairfield Clinical Trials, Llc Peri-operative and peri-procedure nutritional supplementation
US20040208939A1 (en) * 2003-04-18 2004-10-21 Barry Sears Novel dietary compositions to reduce inflammation
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
EP1718163A1 (en) * 2004-02-23 2006-11-08 The Texas A&M University System Antioxidant compositions and methods of use thereof
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US8663679B2 (en) * 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
CN100382797C (zh) * 2004-10-28 2008-04-23 昆明翔昊科技有限公司 含叶黄素和/或胡萝卜素亚麻酸的配方产品及其制备方法
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
EP1714564A1 (en) * 2005-04-21 2006-10-25 N.V. Nutricia Method for treatment and prevention of respiratory insufficiency
FR2885491B1 (fr) * 2005-05-16 2020-03-06 Nutricos Technologies Traitement de la secheresse keratinique par des glycerides
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
ATE418976T1 (de) * 2005-08-04 2009-01-15 Extarma Ag Flüssige zusammensetzung enthaltend arginine und alpha-liponsäure zur verbesserung der sexuellen funktion
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7436412B2 (en) * 2005-08-24 2008-10-14 Qualcomm Incorporated Graphics engine with efficient interpolation
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
ES2548432T3 (es) * 2005-12-19 2015-10-16 Abbott Laboratories Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2
DK1800675T3 (da) 2005-12-23 2011-09-05 Nutricia Nv Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
WO2007100560A2 (en) * 2006-02-28 2007-09-07 Bristol-Myers Squibb Company Use of dha and ara in the preparation of a composition for inducing the expression of pulmonary surfactant protein-b
US20070298079A1 (en) * 2006-06-26 2007-12-27 Tropicana Products, Inc. Food fortified with omega-3 fatty acids
CA2567879C (en) * 2006-11-14 2013-03-26 Thomas Greither Nutritional food oil compositions and methods of making same
US20100178273A1 (en) * 2007-06-20 2010-07-15 Actogenix Nv Corporation Methods and compositions for treating mucositis
WO2009009040A2 (en) * 2007-07-06 2009-01-15 Baum Seth J Fatty acid compositions and methods of use
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
WO2009139167A1 (ja) * 2008-05-15 2009-11-19 明治乳業株式会社 エネルギー量、水分量および食塩換算量を調整できる栄養組成物
WO2010126353A1 (en) 2009-04-27 2010-11-04 N.V. Nutricia Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
DE102010002558A1 (de) 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
WO2011071365A1 (en) 2009-12-07 2011-06-16 N.V. Nutricia Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding
BR112012018174A2 (pt) 2010-01-29 2019-08-27 Abbott Lab líquidos nutricionais embalados assepticamente compreendendo hmb.
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
JP5892948B2 (ja) 2010-01-29 2016-03-23 アボット・ラボラトリーズAbbott Laboratories カルシウムhmbを含む栄養エマルジョン
CN102843920A (zh) * 2010-01-29 2012-12-26 N·V·努特里奇亚 适用于管饲的、使上消化道和下消化道病症最小化的液体肠营养组合物
US8372465B2 (en) 2010-02-17 2013-02-12 Bunge Oils, Inc. Oil compositions of stearidonic acid
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣hmb及可溶性蛋白質之實質上透明營養液
EP3245875B1 (en) 2010-12-29 2021-05-26 Abbott Laboratories Nutritional product for use in reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child
WO2012164083A1 (en) 2011-06-01 2012-12-06 Actogenix N.V. Polycistronic expression system for bacteria
WO2013046219A1 (en) * 2011-06-16 2013-04-04 Abbott Healthcare Privated Limited Pharmaceutical composition comprising lecithin and process for preparing thereof
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
WO2013041621A1 (de) 2011-09-20 2013-03-28 Basf Se Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US9980939B2 (en) 2013-03-13 2018-05-29 Abbott Laboratories Composition for enhancing newborn infant cognitive, brain and/or CNS development and method of using same
CN105188409A (zh) 2013-03-13 2015-12-23 雅培制药有限公司 含有RRRα-生育酚的婴儿营养产品
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
US11382980B2 (en) 2013-10-08 2022-07-12 Taiyo Kagaku Co., Ltd. Oil/fat composition containing polyunsaturated fatty acid
US10499682B2 (en) 2014-08-25 2019-12-10 New Age Beverage Corporation Micronutrient formulation in electronic cigarettes
CN104719891A (zh) * 2015-03-05 2015-06-24 陈学沛 一种提高免疫力的保健品
CA3011331C (en) 2016-01-14 2025-05-13 Intrexon Actobiotics N.V. Compositions and methods for the treatment of type 1 diabetes
JP7016865B2 (ja) 2016-09-02 2022-03-03 イントレクソン・アクトバイオテイクス・エヌブイ Il-10およびインスリンを安定的に発現する遺伝子改変された細菌
CN109983028B (zh) 2016-09-13 2023-10-20 英特瑞克斯顿阿克图比奥帝克斯有限公司 黏膜黏附性微生物
EP3675809B1 (de) 2017-08-31 2023-09-27 Basf Se Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
CA3156035A1 (en) 2019-09-27 2021-04-01 Intrexon Actobiotics Nv D/B/A Precigen Actobio Treatment of celiac disease
WO2021222535A1 (en) * 2020-05-01 2021-11-04 Irazu Bio Method for treating respiratory viral infections comprising administration of fatty acid compositions
CN112891304B (zh) * 2020-10-14 2022-06-10 麦孚营养科技有限公司 一种高能量密度的脂肪乳剂及其制备方法和其应用
CN113827636B (zh) * 2021-09-10 2022-03-29 中南大学湘雅二医院 藏四味清肺合剂及其在制备治疗呼吸系统疾病药物中的应用
CN114246331B (zh) * 2021-12-10 2023-03-24 江南大学 一种适用于慢性阻塞性肺疾病病人特殊医学用途的全营养配方食品

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621048A5 (es) * 1977-04-27 1981-01-15 Nestle Sa
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
US4737489A (en) * 1983-05-16 1988-04-12 Massachusetts Institute Of Technology Method and composition for treating neurological disorders and aging
US4775665A (en) * 1983-05-16 1988-10-04 Massachusetts Institute Of Technology Method and composition for treating neurological disorders and aging
DE3603000A1 (de) * 1986-01-31 1987-08-06 Milupa Ag Neue polyensaeure-reiche fettmischung und deren verwendung bei der herstellung von saeuglingsnahrungen
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
FR2604606B1 (fr) * 1986-10-07 1994-01-14 Gervais Danone Cie Nouvel aliment lacte dietetique infantile
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
US4880912A (en) * 1987-04-24 1989-11-14 Abbott Laboratories Dispersion and neutralization of acid casein
US4832975A (en) * 1987-09-29 1989-05-23 The Procter & Gamble Company Tailored triglycerides having improved autoignition characteristics
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
US4874629A (en) * 1988-05-02 1989-10-17 Chang Stephen S Purification of fish oil
US5023100A (en) * 1988-05-02 1991-06-11 Kabi Vitrum Ab Fish oil
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
US5000975A (en) * 1988-12-29 1991-03-19 American Home Products Corporation Randomized palm oil fat composition for infant formulas
US5116819A (en) * 1989-05-05 1992-05-26 Clintec Nutrition Co. Enteral diet for patients with pulmonary disease
DE3920679A1 (de) * 1989-06-23 1991-01-10 Milupa Ag Fettmischung zur herstellung von nahrungen, insbesondere saeuglingsnahrungen
KR920007672B1 (ko) * 1990-02-10 1992-09-14 한국식품개발연구원 오메가 지방산 함량이 높고 콜레스테롤 함량이 적은 고기를 생산하기 위한 지방사료첨가제의 제조방법
US5013569A (en) * 1990-05-21 1991-05-07 Century Laboratories, Inc. Infant formula

Also Published As

Publication number Publication date
MX9301787A (es) 1994-02-28
CA2129452C (en) 2003-09-23
JPH0811048B2 (ja) 1996-02-07
DE69329201D1 (de) 2000-09-14
NZ249397A (en) 1996-01-26
EP0656754A1 (en) 1995-06-14
WO1993019624A1 (en) 1993-10-14
CA2129452A1 (en) 1993-10-14
GR3034742T3 (en) 2001-02-28
EP0656754B1 (en) 2000-08-09
US5223285A (en) 1993-06-29
AU659931B2 (en) 1995-06-01
JPH07501457A (ja) 1995-02-16
DE69329201T2 (de) 2001-04-12
HK1011913A1 (en) 1999-07-23
AU3614693A (en) 1993-11-08
EP0656754A4 (en) 1995-03-02

Similar Documents

Publication Publication Date Title
ES2150440T3 (es) Producto nutritivo para pacientes que padecen una enfermedad pulmonar.
EP0440309B1 (en) Pharmaceutical and dietary composition
Ruthig et al. Both (n-3) and (n-6) fatty acids stimulate wound healing in the rat intestinal epithelial cell line, IEC-6
Holub Fish oils and cardiovascular disease
Rambjør et al. Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans
Jolly et al. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide
JP4555471B2 (ja) ストレスにより誘発された免疫抑制を低減する製品および方法
MX9304468A (es) Producto nutritivo enteral para personas que tienen un daño neurologico.
Sowers et al. Vitamins and arthritis: the roles of vitamins A, C, D, and E
KR940018091A (ko) 불포화 지방산을 포함하는 처방
ES2168157T3 (es) Alimento o suplemento nutritivo, su procedimiento de preparacion y sus utilizaciones.
CN1099610A (zh) 用于吸烟者的制剂
ATE361066T1 (de) Polyungesättigen fettsäuren nährungsergänzung
Horrobin A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2
Kremer Clinical studies of omega-3 fatty acid supplementation in patients who have rheumatoid arthritis
ES2171535T3 (es) Producto nutritivo utilizado en el tratamiento de la colitis ulcerosa y su uso.
Campbell Clinical use of fatty acid supplements in dogs
Burns et al. Biochemical effects of lipids on cancer therapy
Sanders Influence of fish-oil supplements on man
AU1489688A (en) Omega-3 fatty acids in traumatic injury treatment
EP0273407A3 (en) Medicine for improving the specific properties of blood
Duran The pharmacological evaluation of flax seed oil
Kumar et al. Lipid peroxides and essential fatty acids in patients with coronary heart disease
Hänninen et al. Dose-response relationships in blood lipids during moderate freshwater fish diet
Minnis et al. Oily fish and fish oil supplements in the prevention of coronary heart disease

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 656754

Country of ref document: ES